recursion.com (RXRX) Company Value to Net Income

Recursion Pharmaceuticals - graphic logo of issuer RXRX

Recursion Pharmaceuticals (RXRX) relies on a powerful complex of biolabs and its own supercomputer. The company's price-to-earnings ratio demonstrates asset dynamics, where the metric value is -4.60. The business scales drug discovery through alliances with IT leaders. Intellectual capital in the form of a biological database is monetized through patents and partnership agreements.

Recursion Pharmaceuticals Inc (RXRX) P/E Multiple: for the period 07/04/2022 - 11/10/2026

Analytical breakdowns for Recursion Pharmaceuticals

- price and consensus price forecast:
Stock Price Recursion Pharma|RXRX - Price Target Chart
- market capitalization details:
Market Value Recursion Pharmaceuticals, Inc.|RXRX - Total Company Value
- balance sheet net asset value indicators:
Net Assets per Share Recursion|RXRX - Book Capitalization|Market Capitalization to Book Value recursion.com|RXRX - Aggregate Company Assets
- company liabilities and liquidity data:
Debt to Capital Recursion Pharmaceuticals|RXRX - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio recursion.com|RXRX - Company Total Debt|Debt to Net Assets Ratio Recursion Pharmaceuticals, Inc.|RXRX - Company Long-Term Debt|Current Liabilities Recursion|Intermediate Coverage Ratio recursion.com
- earnings and market multiples details:
RXRX - Net Profit|Projected Future Earnings Recursion Pharmaceuticals|RXRX - Price to Earnings Ratio|Future Price to Earnings Multiple Recursion Pharmaceuticals Inc|RXRX - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Recursion Pharmaceuticals, Inc.|RXRX - Operating profit EBITDA|Net earnings per share (EPS TTM) Recursion|RXRX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months recursion.com|RXRX - Earnings growth in current year|Expected net earnings per share growth next year Recursion Pharmaceuticals
General company analysis:Recursion Pharmaceuticals, Inc. - RXRX
Original product of Recursion Pharmaceuticals, Inc.

The P/E ratio relates market capitalization to net income, allowing for an assessment of the asset's overvaluation and the identification of potential price manipulations. By analyzing the P/E chart for Recursion Pharmaceuticals (RXRX), an investor can compare market expectations with actual returns, which is critical for Recursion Pharmaceuticals (RXRX) given its high capital burn rate and the uncertainty surrounding the results of its AI platform trials.

Analysis of competing companies

P/E Multiple nvidia.com|Price to Earnings Ratio CoreWeave (CRWV)|NBIS (Nebius Group N.V) - Company Value to Net Income|Price to Earnings Ratio SoundHound Inc. SOUN|Business Payback Period Zeta Global (ZETA)|Pagaya Technologies - P/E Multiple|Business Payback Period C3.ai, Inc. AI|Rezolve AI (RZLV) - Price to Earnings Ratio|Market Cap to Earnings Super X AI (SUPX)|Price to Earnings Ratio Ginkgo Bioworks Holdings|Price to Earnings Multiple CRNC (Cerence AI)|Price to Earnings Ratio PDYN (Palladyne AI Corp.)|VERI (veritone.com) - Company Value to Net Income|Price to Earnings Ratio Mint Inc. MIMI|MLGO (MicroAlgo Inc) - Market Cap to Net Income|Helport AI Limited - P/E Multiple|Company Value to Net Income LPSN (LivePerson Inc.)|QUIK: P/E Multiple|System1 (SST) - P/E Multiple|Price to Earnings Ratio Datavault AI|RYET: Company Value to Net Income|Price to Earnings Ratio Webus (WETO)|Price to Earnings Ratio Micropolis Corp MCRP|P/E Multiple CYN (Cyngn)|P/E Multiple Connexa Sports Technologies, Inc. YYAI|MicroCloud Hologram Inc - P/E Multiple|MultiSensor AI Holdings Inc. (MSAI) - Price to Earnings Ratio|EVAX: P/E Multiple|Market Cap to Earnings Xiaoi Corporation (AIXI)|Price to Earnings Ratio CXAI|P/E Multiple Brand Engagement Network Inc|Price to Earnings Ratio GXAI (Gaxos.ai Inc.)|Market Price to Net Income Ratio EVGN|P/E Multiple IFBD (Infobird)|Business Payback Period China Information Technology (TAOP)|VERSES Technologies - P/E Multiple|Exscientia plc (EXAI) - Price to Earnings Ratio|FOXO: P/E Multiple|Vocodia Holdings (VHAI) - P/E Multiple|Price to Earnings Ratio Zapata Computing